Zein Dib, PharmD
Pharmacy Resident, Option Care Health
Describe your session in a tweet.
This session will provide a closer look at EMRELIS™ (telisotuzumab vedotin-tllv) mechanism of action, dosing & administration, safety considerations, and it's impact on home infusion practice.
What is the most important thing you want attendees to take away from your session?
Attendees will gain an overview of EMRELIS™ (telisotuzumab vedotin-tllv) starting from its indication to the operational and safety considerations that come with administration in home settings. The session emphasizes how these factors translate into real-world decision-making, patient monitoring, and care coordination, helping clinicians and teams anticipate challenges, manage risk, and support safe, effective therapy delivery.
Excluding your session, what other topics are you passionate about in relation to the home and alternate site industry?
I am passionate about expanding access to therapies through the home and alternate site-of-care setting while maintaining a strong focus on medication safety. This includes safely transitioning complex and high-risk therapies into the home, implementing standardized processes to reduce medication-use errors, and ensuring patients can receive personalized, targeted treatment in a setting that improves access, convenience, and continuity of care.
If you had a paid year off work, how would you spend it?
I’d spend a paid year off doing nothing for six months, feeling guilty about it for five, and using the last month to swear I’ve been ‘very busy.’
If you had a secret identity, what would your alias be and what would you be known for?
"Luther", I’d be the person in the van known for hacking everything, saving the mission, and never getting enough credit or screen time.
What’s your “it’s not a big deal, but it is” hill to die on?
Pineapple does not go on pizza. I won’t debate it, I won’t explain it, and I will absolutely judge you quietly.
